Research progress on the application of ultrasound-targeted microbubble destruction technology in the treatment of liver cancer

doi:10.3760/cma.j.cn371439-20240618-00122

Abstract

Abstract:

Commonly used treatments for liver cancer include ablation therapy， surgical resection， liver transplantation， etc. With the further development of ultrasound therapy technology and molecular imaging technology， ultrasound-targeted microbubble destruction （UTMD） technology has become an emerging means of tumor diagnosis and treatment. Ultrasound microbubbles can not only diagnose and develop， but also can be used as a new drug or gene delivery system， enabling targeted delivery of drugs or genes to treat diseases. This technology has great potential in the treatment of liver cancer. Exploring the mechanism， application and related issues of UTMD in the treatment of liver cancer can bring new treatment options for liver cancer patients.

Key words: Liver neoplasms, Microbubbles, Phonophoresis

Jiang Qiong, Yu Jinhong. Research progress on the application of ultrasound-targeted microbubble destruction technology in the treatment of liver cancer[J]. Journal of International Oncology, 2024, 51(11): 723-727.

References 39

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
[2]	Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches[J]. Biochim Biophys Acta Rev Cancer, 2020, 1873(1): 188314. DOI: 10.1016/j.bbcan.2019.188314.
[3]	Han F, Wang Y, Dong X, et al. Clinical sonochemotherapy of inoperable pancreatic cancer using diagnostic ultrasound and microbubbles: a multicentre, open-label, randomised, controlled trial[J]. Eur Radiol, 2024, 34(3): 1481-1492. DOI: 10.1007/s00330-023-10210-4.
[4]	Moore-Palhares D, Dasgupta A, Saifuddin M, et al. Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: a phase 1 clinical trial[J]. PLoS Med, 2024, 21(5): e1004408. DOI: 10.1371/journal.pmed.1004408.
[5]	Zahiri M, Taghavi S, Abnous K, et al. Theranostic nanobubbles towards smart nanomedicines[J]. J Control Release, 2021, 339: 164-194. DOI: 10.1016/j.jconrel.2021.09.032.
[6]	Li J, Xi A, Qiao H, et al. Ultrasound-mediated diagnostic imaging and advanced treatment with multifunctional micro/nanobubbles[J]. Cancer Lett, 2020, 475: 92-98. DOI: 10.1016/j.canlet.2020.01.028. pmid: 32032678
[7]	Erlichman DB, Weiss A, Koenigsberg M, et al. Contrast enhanced ultrasound: a review of radiology applications[J]. Clin Imaging, 2020, 60(2): 209-215. DOI: 10.1016/j.clinimag.2019.12.013.
[8]	Kancheva M, Aronson L, Pattilachan T, et al. Bubble-based drug delivery systems: next-generation diagnosis to therapy[J]. J Funct Biomater, 2023, 14(7): 373. DOI: 10.3390/jfb14070373.
[9]	Jose AD, Wu Z, Thakur SS. A comprehensive update of micro-and nanobubbles as theranostics in oncology[J]. Eur J Pharm Biopharm, 2022, 172: 123-133. DOI: 10.1016/j.ejpb.2022.02.008.
[10]	Myers JZ, Navarro-Becerra JA, Borden MA. Nanobubbles are non-echogenic for fundamental-mode contrast-enhanced ultrasound imaging[J]. Bioconjug Chem, 2022, 33(6): 1106-1113. DOI: 10.1021/acs.bioconjchem.2c00155.
[11]	Sitta J, Howard CM. Applications of ultrasound-mediated drug delivery and gene therapy[J]. Int J Mol Sci, 2021, 22(21): 11491. DOI: 10.3390/ijms222111491.
[12]	Sun S, Wang P, Sun S, et al. Applications of micro/nanotechnology in ultrasound-based drug delivery and therapy for tumor[J]. Curr Med Chem, 2021, 28(3): 525-547. DOI: 10.2174/09298673276 66200212100257.
[13]	Sasaki N, Bos C, Escoffre JM, et al. Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetration[J]. Int J Pharm, 2015, 482(1/2): 118-122. DOI: 10.1016/j.ijpharm.2015.01.039.
[14]	Johansen ML, Perera R, Abenojar E, et al. Ultrasound-based molecular imaging of tumors with PTPmu biomarker-targeted nanobubble contrast agents[J]. Int J Mol Sci, 2021, 22(4): 1983. DOI: 10.3390/ijms22041983.
[15]	Zhou H, Liu H, Zhang Y, et al. "PFH/AGM-CBA/HSV-TK/LIPOSOME-Affibody": novel targeted nano ultrasound contrast agents for ultrasound imaging and inhibited the growth of ErbB2-overexpressing gastric cancer cells[J]. Drug Des Devel Ther, 2022, 16: 1515-1530. DOI: 10.2147/DDDT.S351623.
[16]	Omata D, Munakata L, Maruyama K, et al. Enhanced vascular permeability by microbubbles and ultrasound in drug delivery[J]. Biol Pharm Bull, 2021, 44(10): 1391-1398. DOI: 10.1248/bpb.b21-00453. pmid: 34602547
[17]	Han Y, Sun J, Wei H, et al. Ultrasound-targeted microbubble destruction: modulation in the tumor microenvironment and application in tumor immunotherapy[J]. Front Immunol, 2022, 13: 937344. DOI: 10.3389/fimmu.2022.937344.
[18]	Hu Y, Wei J, Shen Y, et al. Barrier-breaking effects of ultrasonic cavitation for drug delivery and biomarker release[J]. Ultrason Sonochem, 2023, 94: 106346. DOI: 10.1016/j.ultsonch.2023.106346.
[19]	Zhou LQ, Li P, Cui XW, et al. Ultrasound nanotheranostics in fighting cancer: advances and prospects[J]. Cancer Lett, 2020, 470: 204-219. DOI: 10.1016/j.canlet.2019.11.034. pmid: 31790760
[20]	Xiang X, Pang H, Ma T, et al. Ultrasound targeted microbubble destruction combined with Fe-MOF based bio-/enzyme-mimics nanoparticles for treating of cancer[J]. J Nanobiotechnology, 2021, 19(1): 92. DOI: 10.1186/s12951-021-00835-2.
[21]	Luo T, Bai L, Zhang Y, et al. Optimal treatment occasion for ultrasound stimulated microbubbles in promoting gemcitabine delivery to VX2 tumors[J]. Drug Deliv, 2022, 29(1): 2796-2804. DOI: 10.1080/10717544.2022.2115163. pmid: 36047064
[22]	Wu Y, Sun T, Tang J, et al. Ultrasound-targeted microbubble destruction enhances the antitumor efficacy of doxorubicin in a mouse hepatocellular carcinoma model[J]. Ultrasound Med Biol, 2020, 46(3): 679-689. DOI: 10.1016/j.ultrasmedbio.2019.09.017. pmid: 31882167
[23]	Haram M, Hansen R, Bouget D, et al. Treatment of liver metastases with focused ultrasound and microbubbles in patients with colorectal cancer receiving chemotherapy[J]. Ultrasound Med Biol, 2023, 49(9): 2081-2088. DOI: 10.1016/j.ultrasmedbio.2023.05.013. pmid: 37336691
[24]	Marshall E. Gene therapy death prompts review of adenovirus vector[J]. Science, 1999, 286(5448): 2244-2245. DOI: 10.1126/science.286.5448.2244. pmid: 10636774
[25]	Pan Y, Wei M, Gong T. Ultrasound microbubble-mediated delivery of ANLN silencing-repressed EZH2 expression alleviates cervical cancer progression[J]. Tissue Cell, 2022, 77: 101843. DOI: 10.1016/j.tice.2022.101843.
[26]	Zhou X, Liu H, Pang Y, et al. UTMD-mediated delivery of miR-21-5p inhibitor suppresses the development of lung cancer[J]. Tissue Cell, 2022, 74: 101719. DOI: 10.1016/j.tice.2021.101719.
[27]	Wang H, Hu Z, Sukumar UK, et al. Ultrasound-guided microbubble-mediated locoregional delivery of multiple microRNAs improves chemotherapy in hepatocellular carcinoma[J]. Nanotheranostics, 2022, 6(1): 62-78. DOI: 10.7150/ntno.63320. pmid: 34976581
[28]	Wu H, Xie D, Yang Y, et al. Ultrasound-targeted microbubble destruction-mediated miR-206 overexpression promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells via targeting PPIB[J]. Technol Cancer Res Treat, 2020, 19: 1533033820959355. DOI: 10.1177/1533033820959355.
[29]	Anderson CD, Arthur JA, Zhang Y, et al. Non-viral in vivo cytidine base editing in hepatocytes using focused ultrasound targeted microbubbles[J]. Mol Ther Nucleic Acids, 2023, 33: 733-737. DOI: 10.1016/j.omtn.2023.07.032.
[30]	Kumar SU, Telichko AV, Wang H, et al. Acoustically driven microbubbles enable targeted delivery of microRNA-loaded nanoparticles to spontaneous hepatocellular neoplasia in canines[J]. Adv Ther (Weinh), 2020, 3(12): 2000120. DOI: 10.1002/adtp.202000120.
[31]	Sharma D, McNabb E, Law N, et al. Ultrasound-stimulated microbubbles enhancement of fractionated radiation for tumor treatment[J]. BMC Cancer, 2023, 23(1): 693. DOI: 10.1186/s12885-023-10981-5. pmid: 37488490
[32]	Yang Y, Dang Z, Lu P, et al. Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a multicenter propensity score matching analysis[J]. Hepatobiliary Surg Nutr, 2022, 11(3): 386-399. DOI: 10.21037/hbsn-20-700.
[33]	Morse MA, Sun W, Kim R, et al. The role of angiogenesis in hepatocellular carcinoma[J]. Clin Cancer Res, 2019, 25(3): 912-920. DOI: 10.1158/1078-0432.CCR-18-1254. pmid: 30274981
[34]	Kim D, Lee JH, Moon H, et al. Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model[J]. Theranostics, 2021, 11(1): 79-92. DOI: 10.7150/thno.45348. pmid: 33391462
[35]	Sultan LR, D'Souza JC, Karmacharya MB, et al. Dose-dependent effects of ultrasound therapy on hepatocellular carcinoma[C]// 2020 IEEE International Ultrasonics Symposium (IUS). Las Vegas, NV, USA: IEEE, 2020: 1-4. DOI: 10.1109/IUS46767.2020.9251660.
[36]	Eisenbrey JR, Forsberg F, Wessner CE, et al. US-triggered microbubble destruction for augmenting hepatocellular carcinoma response to transarterial radioembolization: a randomized pilot clinical trial[J]. Radiology, 2021, 298(2): 450-457. DOI: 10.1148/radiol.2020202321. pmid: 33320067
[37]	Xiao S, Hu Z, He Y, et al. Enhancement effect of microbubble-enhanced ultrasound in microwave ablation in rabbit VX2 liver tumors[J]. Biomed Res Int, 2020, 2020: 3050148. DOI: 10.1155/2020/3050148.
[38]	胡志文, 萧淑宜, 格桑卓玛, 等. 微泡超声空化在增强微波消融对肝脏肿瘤的热消融效应中的价值[J]. 广州医药, 2021, 52(1): 43-48. DOI: 10.3969/j.issn.1000-8535.2021.01.009.
[39]	益磋, 王亚辉, 陈重, 等. 超声空化促进乙醇消融兔肝脏的实验研究[J]. 中华医学超声杂志 (电子版), 2017, 14(12): 948-954. DOI: 10.3877/cma.j.issn.1672-6448.2017.12.014.